{"a": [["Safety of Diamyd\u00ae in Patients With LADA (Latent Autoimmune Diabetes in Adult)", "December 2004"], ["Randomised, controlled, parallel\u2010group study to investigate the clinical effectiveness of early insulin treatment in patients with LADA", "2007"], ["Non Insulin Requiring Autoimmune Diabetes (NIRAD) project", "2006"], ["Is &quot;Beta Cell Rest&quot; by Insulin Treatment Beneficial Compared to State\u2010of\u2010the Art Enhancers of Insulin Secretion in Preserving Beta Cell Function in Subjects With Latent Autoimmune Diabetes of the Adult (LADA)?", "March 2009"], ["Rosiglitazone intervention study on patients with type 1.5 diabetes", "2000"], ["Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA)", "October 2002"], ["Protective Effects of Sitagliptin on \u03b2 Cell Function in Patients With Adult\u2010onset Latent Autoimmune Diabetes(LADA) (DPP\u2010\u2163LADA)", "May 2010"], ["Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta\u2010analysis", "2007"], ["Latent autoimmune diabetes of adulthood (LADA): an often misdiagnosed type of diabetes mellitus", "2009"], ["Thiazolidinediones for the prevention of diabetes in the non\u2010obese diabetic (NOD) mouse: implications for human type 1 diabetes", "2002"], ["Diabetes Antibody Standardization Program, first assay proficiency evaluation", "2003"], ["Meglitinide analogues for type 2 diabetes mellitus", "2003"], ["Epidemiology of latent autoimmune diabetes [LADA] in eight centres in Europe", "2006"], ["Experience of the introduction of routine antibody testing in primary care and of running a trial for latent autoimmune diabetes in adults (LADA)", "2011"], ["Slowly progressing type 1 diabetes: persistence of islet cell autoantibodies is related to glibenclamide treatment", "2002"], ["A coefficient of agreement for nominal scales", "1960"], ["Latent autoimmune diabetes in adults (LADA) in South Wales: incidence and characterization", "2008"], ["Latent autoimmune diabetes in adults: a guide for the perplexed", "2005"], ["Quantifying heterogeneity in a meta\u2010analysis", "2002"], ["Measuring inconsistency in meta\u2010analysis", "2003"], ["Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]", "2005"], ["Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]", "2011"], ["Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta\u2010cell failure in islet cell antibody\u2010positive patients with clinical features of NIDDM", "1996"], ["Insulin intervention to preserve beta cells in slowly progressive insulin\u2010dependent (type 1) diabetes mellitus", "2002"], ["The case of the misleading funnel plot", "2006"], ["Type 1 diabetes and latent autoimmune diabetes in adults (LADA): one end of the rainbow", "2006"], ["Forest plots: trying to see the wood and the trees", "2001"], ["The PRISMA statement for reporting systematic and meta\u2010analyses of studies that evaluate interventions: explanation and elaboration", "1999"], ["Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA)", "2001"], ["Multicenter prevention trial of slowly progressive type 1 diabetes with small dose of insulin (the Tokyo study): preliminary report", "2003"], ["Latent autoimmune diabetes of adulthood. Unique features that distinguish it from type 1 and 2", "2005"], ["Latent autoimmune diabetes in adults (LADA)", "2003"], ["Latent autoimmune diabetes in adults", "2009"], ["Etiological investigation of diabetes in young adults presenting with apparent type 2 diabetes", "2003"], ["Beta cell rest and recovery \u2010 does it bring patients with latent autoimmune diabetes in adults to euglycaemia?", "2002"], ["Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization and potential prevention", "2001"], ["Pioglitazone for type 2 diabetes mellitus", "2006"], ["Rosiglitazone for type 2 diabetes mellitus", "2007"], ["Dipeptidyl peptidase\u20104 (DPP\u20104) inhibitors for type 2 diabetes mellitus", "2008"], ["Metformin monotherapy for type 2 diabetes mellitus", "2005"], ["Progress in the characterization of slowly progressive autoimmune diabetes in adult patients (LADA or type 1.5 diabetes)", "2001"], ["Quality of life considerations for insulin versus oral agent therapy in persons presenting with characteristics of latent autoimmune diabetes in adults [LADA]", "2004"], ["Section II: Type 1\u2010 related forms of diabetes. Latent autoimmune diabetes in adults", "2005"], ["Investigating and dealing with publication and other biases", "2001"], ["Clinical, autoimmune, and genetic characteristics of adult\u2010onset diabetic patients with GAD auto\u2010antibodies in Japan (Ehime Study)", "2002"], ["The preliminary report from the nation\u2010wide prevention study for type 1 diabetes initially diagnosed as type 2 in Japan", "1998"], ["Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non\u2010insulin\u2010dependent onset of disease", "1993"], ["UKPDS 25: autoantibodies to islet\u2010cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group", "1997"], ["Alpha\u2010glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose", "2006"], ["Rosiglitazone combined with insulin preserves islet beta cell function in adult\u2010onset latent autoimmune diabetes (LADA)", "2004"], ["Phenotypic characteristics of GAD antibody\u2010positive recently diagnosed patients with type 2 diabetes in North America and Europe", "2004"]], "ex": [["Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic control in recently diagnosed type 2 diabetes patients", "2003"], ["GAD65 autoantibody epitopes in adult patients with latent autoimmune diabetes following GAD65 vaccination", "2007"], ["Diazoxide treatment at onset preserves residual insulin secretion in adults with autoimmune diabetes", "1996"], ["Oral insulin administration and residual Beta cell function in recent onset type 1 diabetes: a Multicentre randomised controlled trial", "2000"], ["Lack of effect of intermittently administered sodium fusidate in patients with newly diagnosed type 1 diabetes mellitus: the FUSIDM trial", "2005"], ["Effect of intensive therapy on residual beta cell function in patients with type 1 diabetes in the diabetes control and complications trial", "1998"], ["GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77", "2007"], ["Autoimmune diabetes in adults: lessons from the UKPDS", "2008"], ["Oral insulin therapy to prevent progression of immune\u2010mediated (type 1) diabetes", "2004"], ["Effects of a short prednisone regime at clinical onset of type 1 diabetes", "1993"], ["The effect of insulin antibodies on the metabolic action of inhaled and subcutaneous insulin", "2005"], ["Complete long term recovery of beta cell function in autoimmune type 1 diabetes after insulin treatment", "2004"], ["Insulin intervention to preserve beta cells in slowly progressive insulin dependent (type 1) diabetes mellitus", "2002"], ["Intervention in patients with type 1 diabetes masquerading as type II diabetes", "1996"], ["Diabetes classification:grey zones, sound and smoke: Action LADA1", "2008"], ["Intensive therapy in adult insulin dependent diabetes mellitus is associated with improved insulin sensitivity and reserve: a randomised, controlled prospective study over 5 years in newly diagnosed patients", "1996"], ["Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment", "1999"], ["Detection of LADA\u2010type diabetes in overweight diabetic patients. Is treatment with metformin suitable?", "2007"], ["Follow\u2010up of cyclosporin A, treatment in type 1 (insulin \u2010 dependent) diabetes mellitus: lack of long term effects", "1991"], ["Small doses of insulin may prevent the decrease of intrinsic insulin secretion in anti\u2010GAD, ICA and IA\u20102 antibody\u2010positive slowly progressive type 1 diabetes", "2005"], ["UKPDS 26: Sulphonylurea failure in non\u2010insulin dependent diabetic patients over six years", "1998"], ["Influence of insulin treatment on insulin sensitivity in insulin requiring type 2 diabetes patients", "2005"], ["Anti\u2010thyroid peroxidase antibody, IA\u20102 antibody and fasting C\u2010peptide levels predict beta cell failure in patients with latent autoimmune diabetes in adults (LADA). A 5 year follow\u2010up of the Ehime study", "2008"], ["Effect of Rosiglitazone versus insulin on the pancreatic beta cell function of subjects with type 2 diabetes", "2004"], ["Vitamin E and nicotinamide have similar effects in maintaining residual beta cell function in recent onset insulin dependent diabetes (the IMDIAB IV study)", "1997"], ["No effect of oral insulin on residual beta\u2010cell function in recent\u2010onset type 1 diabetes (the IMDIAB VII)", "2000"], ["Peptide\u2010based treatment for autoimmune diseases: learning how to handle a double\u2010edged sword", "2003"], ["Insulin versus a combination of insulin and sulphonylurea in the treatment of NIDDM patients with secondary oral failure", "1995"], ["Treatment of new\u2010onset type 1 diabetes with peptide DiaPep277 is safe and associated with preserved beta\u2010cell function: extension of a randomised, double\u2010blind, phase II trial", "2007"], ["Latent Autoimmune Diabetes in Adults (LADA): Usefulness of Anti\u2010Gad Antibody Titers and Benefit of Early Insulinization", "2007"], ["Non\u2010obese adult onset diabetes with oral hypoglycaemic agent failure: islet cell autoantibodies or reversible beta cell refractoriness?", "2003"], ["Effect of heat shock protein peptide DiaPep277 on Beta\u2010cell function in paediatric and adult patients with recent\u2010onset diabetes mellitus type 1: two prospective, randomised, double\u2010blind phase II trials", "2007"], ["Islet\u2010cell antibodies and type 1 diabetes after treatment with interferon\u2010alpha", "2004"], ["Quality of life considerations for insulin versus oral agent therapy in persons presenting with characteristics of latent autoimmune diabetes in adults [LADA]", "2004"], ["Prednisone administration in recent onset type 1 diabetes", "1990"], ["Beta cell Function and the development of diabetes related complications in the diabetes control and complications trial", "2003"], ["Latent autoimmune diabetes in adults: Definition, prevalence, Beta cell function and treatment", "2005"], ["The preliminary report from the nation\u2010wide prevention study for type 1 diabetes initially diagnosed as type 2 in Japan", "1998"], ["UKPDS 25: autoantibodies in islet\u2010cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes", "1997"], ["The islet autoantibody titre: their clinical relevance in latent autoimmune diabetes in adults (LADA) and the classification of diabetes mellitus", "2007"], ["Effects of Nicotinamide and intravenous insulin therapy in newly diagnosed type 1 diabetes", "2000"], ["Effect of intensive insulin therapy on Beta\u2010cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a Multicentre randomised parallel\u2010group trial", "2008"], ["Phenotypic Characteristics of GAD antibody positive recently diagnosed patients with type 2 diabetes in north America and Europe", "2004"]], "in": [["Clinical evidence for the safety of GAD65 immunomodulation in adult\u2010onset autoimmune diabetes", "2005"], ["GAD65 vaccination: 5 years of follow\u2010up in a randomised dose\u2010escalating study in adult\u2010onset autoimmune diabetes", "2009"], ["Slowly progressing type 1 diabetes: Persistence of islet cell autoantibodies is related to glibenclamide treatment", "2002"], ["Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control [UKPDS 70]", "2005"], ["Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta cell failure in islet cell antibody positive patients with clinical features of NIDDM", "1996"], ["The role of sulphonylurea in combination therapy assessed in a trial of sulphonylurea withdrawal", "1999"], ["Protective effects of 1\u2010alpha\u2010hydroxyvitamin D3 on residual beta\u2010cell function in patients with adult\u2010onset latent autoimmune diabetes (LADA)", "2009"], ["Multicenter prevention trial of slowly progressive type 1 diabetes with small dose of insulin (the Tokyo Study)", "2003"], ["Insulin Intervention in Slowly Progressive Insulin Dependent (Type 1) Diabetes Mellitus", "2008"], ["Beta\u2010cell function and metabolic control in Latent Autoimmune Diabetes in Adults (LADA) with early insulin vs conventional treatment: A three\u2010year follow\u2010up", "2011"], ["Effect of Tanguikang in improving the function of pancreatic islet beta cells in patients with latent autoimmune diabetes in adults", "2008"], ["Rosiglitazone preserves islet beta\u2010cell function of adult onset latent autoimmune diabetes in 3 years follow\u2010up study", "2009"], ["Rosiglitazone combined with insulin preserves islet beta cell function in adult\u2010onset latent autoimmune diabetes [LADA]", "2005"], ["Study on improvement of islet beta cell function in patients with latent autoimmune diabetes mellitus in adults by integrated Chinese and Western Medicine", "2004"]]}